Profil
William C.
Roberts is currently VP-Investor Relations & Corporate Communications at G1 Therapeutics, Inc. since 2021 and SVP-Corporate Communications & Investor Relations at Aclaris Therapeutics, Inc. starting in 2025.
Former positions include Vice President-Communications & Investor Relations at Shire ViroPharma, Inc., Vice President-Investor Relations & Communications at Harmony Biosciences Management, Inc., Head-Investor Relations at MedImmune LLC, Vice President-Investor Relations at Adaptimmune Therapeutics Plc, and Vice President-Corporate Communications at Viropharma, Inc. Education includes undergraduate studies at the University of Virginia and an MBA from Keller Graduate School of Management.
Aktiva positioner av William C. Roberts
| Företag | Position | Start |
|---|---|---|
| G1 THERAPEUTICS, INC. | Investor Relations Kontakt | 2021-01-04 |
| ACLARIS THERAPEUTICS, INC. | Investor Relations Kontakt | 2025-01-01 |
Tidigare kända positioner av William C. Roberts
| Företag | Position | Slut |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Investor Relations Kontakt | 2017-10-23 |
Viropharma, Inc. | Offentlig kommunikationskontakt | - |
| ZYNERBA PHARMACEUTICALS, INC. | Investor Relations Kontakt | - |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Investor Relations Kontakt | - |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Investor Relations Kontakt | - |
William C. Robertss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Zynerba Pharmaceuticals, Inc.
Zynerba Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Delivers dermal solutions for the treatment of neuroscience disorders | Health Technology |
Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keller Graduate School of Management
Keller Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
G1 Therapeutics, Inc.
G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Adaptimmune Therapeutics Plc
Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
Viropharma, Inc. |
















